<DOC>
	<DOCNO>NCT00934687</DOCNO>
	<brief_summary>Depression frequently accompany specific sad facial expression . This expression part mediate muscle activity produce frown line . Based assumption positive feedback depress mood correspondent facial muscle activity ( facial feedback ) investigator conduct randomize control pilot study investigator apply classical cosmetic treatment frown line injection botulinum toxin depressed patient sufficiently respond antidepressant medication . The investigator hypothesize treatment contribute amelioration depressive symptom patient . This hypothesis support previous open case series remission depression report treatment ( Finzi Wasserman , 2006 ) .</brief_summary>
	<brief_title>Botulinum Toxin Treatment Depression</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Mild moderate depression ( HamD &gt; =15 ) Therapy one antidepressant least four week least moderate frown line Bipolar depression Psychiatric comorbidity Severe somatic comorbidity Pregnancy Peculiarities injection site Psychiatric medication one antidepressant Specific psychotherapy Previous application botulinum toxin Medication interfere botulinum toxin</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>depression</keyword>
	<keyword>depressive</keyword>
	<keyword>botulinum</keyword>
	<keyword>botox</keyword>
</DOC>